Trial Details
RECRUITINGBasic Information
| Clinical ID | c759 |
|---|---|
| Identifier | NCT06095596 |
| Trial Title | Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis (UC) |
| Interventions | DRUG: Upadacitinib|DRUG: Vedolizumab |
Participant Information
| Sponsor | Sixth Affiliated Hospital, Sun Yat-sen University |
|---|---|
| City | Guangdong |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | NA |
Time Information
| Start Date | 2023-11-01 |
|---|---|
| Primary Completion Date | 2025-10-31 |
| Completion Date | 2026-10-31 |